Cutera

Cutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cutera reports strong 2022 performance with focus on AviClear growth

Cutera's performance in 2022 showcased resilience and growth potential, driven by the successful AviClear launch. While facing revenue challenges in Q4 2022, the company is optimistic about achieving cash flow breakeven by Q4 2023. With a bullish outlook for 2023, Cutera aims to leverage its core business strength and accelerate AviClear sales.

Cutera reports Q1 revenue dip, focuses on AviClear growth

Cutera faces challenges in North American sales but sees growth opportunities internationally and with AviClear devices.
Financials show a loss in adjusted EBITDA and decreased cash, but the company is focused on improving execution and driving utilization rates.
Retention incentives have been effective, and steps are being taken to enhance performance and return to sustainable growth.

Cutera reports Q2 revenue decline, focuses on AviClear performance

Cutera reported Q2 2023 revenue of $61.2 million, down 5% YoY, with an adjusted EBITDA loss of $11.6 million. The company is focusing on AviClear performance, quality control, and core business growth.
Challenges include declining core capital business, operational issues, and macroeconomic challenges. Opportunities lie in optimizing AviClear utilization, enhancing reliability, and introducing new products for growth.
Cutera's commitment to addressing challenges, enhancing service levels, and executing a strategic plan for sustainable growth is evident. The organization is resilient in the face of macroeconomic pressures and is adapting its strategies for success.
Retention bonuses, successful employee retention, and efforts to improve quality control measures demonstrate Cutera's internal strengths. The company's strategic approach to product lines and growth showcases a positive outlook for the future.

Cutera reports Q3 revenue decline, focuses on cost reduction

Cutera faces revenue decline and operational challenges in Q3 2023, impacting full-year guidance. Plans for cost reduction, growth strategies, and personnel restructuring in progress. Positive outlook for achieving financial goals with confidence.

Cutera reports Q4 revenue growth, focuses on AviClear expansion

Cutera's Q4 performance reflects resilience with better-than-anticipated revenue and stable AviClear revenue.
Focus on operational excellence, global franchise building, and customer support positions Cutera for long-term success.
Efforts to address challenges like inventory management and customer adoption of new business models are crucial for growth.

Cutera reports mixed Q1 results, focuses on AviClear growth

Cutera's Q1 performance showed a revenue decline but growth in AviClear revenue, with a focus on operational excellence and building a strong AviClear franchise. The company faces challenges with declining customer site volumes and an uncertain timeline for patient demand. However, opportunities exist in international expansion, R&D innovation, and addressing future market needs.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. The pre-recorded fireside will be available for registered attendees via the Piper Sandler conference site from November 24 to December 3. The pre-recorded fireside chat will also be acc

Cutera to Participate in the Piper Sandler Virtual Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced that it will participate in two virtual fireside chats at the following investor conferences in November. Conference: Stifel Virtual Healthcare Conference Date: Tuesday, November 17, 2020 Fireside Chat: 3:20 p.m. ET Speakers: Dave Mowry, Chief Executive Officer Conference: Stephens Virtual Investment Confere

Cutera to Participate in Two Virtual Fireside Chats at Investor Conferences in November

Cutera, Inc. (CUTR) CEO Dave Mowry on Q3 2020 Results - Earnings Call Transcript

Cutera's (CUTR) CEO Dave Mowry on Q3 2020 Results - Quick Version Earnings Call Transcript

Cutera (CUTR) delivered earnings and revenue surprises of 121.05% and 11.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Cutera (CUTR) Beats Q3 Earnings and Revenue Estimates

Shares of Cutera (NASDAQ:CUTR) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 46.67% over the past year to $0.08, which beat the estimate of ($0.34).

Cutera: Q3 Earnings Insights

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Financial and Operational Highlights Revenue was $39.1 million, a 15% decrease from the prior-year period, as COVID-19 disruptions led to a year-over-year decline in capital equipment deals as well as overall

Cutera, Inc. Announces Third Quarter 2020 Financial Results

Cutera (NASDAQ: CUTR) announces its next round of earnings this Wednesday, November 04. Here is Benzinga's look at Cutera's Q3 earnings report.

Earnings Outlook for Cutera

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today announced that it will report financial results for the third quarter 2020 after the market close on Wednesday, November 4, 2020. The Company’s management will host a conference call to the discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day. Participating on the call will

Cutera, Inc. to Announce Third Quarter Results on November 4, 2020

The stock price of Cutera, a medical devices company best known for its aesthetics systems, has rallied 54% since late March (vs. about 50% for the S&P 500) to its current level around $17.

How Does Cutera Stock Performance In 2020 Compare With The 2008 Crisis?

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc.

Cutera to Participate in a Virtual Fireside Chat at the Cantor Global Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC.

Industry Leading truSculpt® flex Launches Its Muscle in Canada

Cutera Reverses Aging, Unveils Powerful Technology

Cutera's (CUTR) CEO Dave Mowry on Q2 2020 Results - Earnings Call Transcript

Cutera to Present at the Canaccord Genuity Growth Conference

Cutera (CUTR) delivered earnings and revenue surprises of 71.60% and 30.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Cutera (CUTR) Reports Q2 Loss, Tops Revenue Estimates

Cutera Appoints Rohan Seth as Chief Financial Officer

Cutera, Inc. Announces Second Quarter 2020 Financial Results

Cutera (CUTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Cutera (CUTR) Q2 Earnings Expected to Decline

Cutera, Inc. to Announce Second Quarter Results on August 6, 2020

Cutera: Currently On Sale

Cutera, Inc. (CUTR) CEO David Mowry on Q1 2020 Results - Earnings Call Transcript

Cutera's (CUTR) CEO Dave Mowry on Q4 2019 Results - Earnings Call Transcript

Inmode Ltd

Sientra

Aesthetics surgery is a big market, and these three companies are positioned to win from its growth.

News for Cutera Stock (CUTR)